Completion of the Verallia North America sale

Pursuant to the agreement signed on January 13, 2013, Saint-Gobain today sold its entire stake in Verallia North America to the Ardagh group based on an enterprise value of US$ 1,694 million (€1,275 million*).

The transaction will reduce the Group’s net debt by an estimated €925 million and follows the agreement reached with the US anti-trust authorities.  

This sale is consistent with Saint-Gobain’s strategy of focusing on high-growth, high value-added markets in habitat and industry. The proceeds from the sale will primarily allow Saint-Gobain to strengthen its balance sheet, but also to continue with its selective acquisitions policy targeting small and mid-scale companies in high-growth countries and in North America, High-Performance Materials and core positions in Building Distribution.

* based on January 2013 exchange rate estimates

About Saint-Gobain

Saint-Gobain, the world leader in the habitat and construction markets, designs, manufactures and distributes building materials, providing innovative solutions to the challenges of growth, energy efficiency and environmental protection. With 2013 sales of €42.0 billion, Saint-Gobain operates in 64 countries and has nearly 190,000 employees. For more information about Saint-Gobain, please visit www.saint-gobain.com.

600450 Completion of the Verallia North America sale glassonweb.com

See more news about:

Others also read

A bright future is ahead for glass, thanks to a serious focus on innovation, the environment, and sustainability, the industry’s annual prestige awards ceremony at the Millennium Gallery in Sheffield heard. (Thurs 22 November).
Let’s re-live the event highlights together.
Saint-Gobain has approved the most important operation planned in Europe, which will be carried out over the next two years.
The façade of the RAL building in Bonn unmistakeably showcases the identity of the client and user of the building.
Glassolutions’ Installation business has relaunched as Facades & Glazing Solutions UK Ltd (FGS) following its sale to private investment firm CoBe Capital.
SUPERCONTRYX - a lead glass should be an extremely important element of your medical facility’s X-ray protection strategy as it attenuates the effect of radiations significantly.

Add new comment